The marked vasodilator and negative inotropic effects of propofol are disadvantages in frail elderly patients. We investigated the safety and efficacy of adding different doses of ephedrine to propofol in order to obtund the hypotensive response. The haemodynamic effects of adding 15, 20 or 25 mg of ephedrine to 200 mg of propofol were compared to control in 40 ASA 3/4 patients over 60 years presenting for genito-urinary surgery. The addition of ephedrine to propofol appears to be an effective method of obtunding the hypotensive response to propofol at all doses used in this study. However, marked tachycardia associated with the use of ephedrine in combination with propofol occurred in the majority of patients, occasionally reaching high levels in individual patients. Due to the risk of this tachycardia inducing myocardial ischemia, we would not recommend the use in elderly patients of any of the ephedrine/propofol mixtures studied.
Propofol is well established as an intravenous anaesthetic induction agent. It has been shown to cause hypotension and bradycardia 1,2 especially in the elderly and the infirm 3 , which makes its use in such patients more difficult. These adverse effects are due to a combination of venous 4 and arterial 5 dilatation and myocardial depression 6, 7 . They are especially marked in the elderly due to their reduced ability to make compensatory changes 8 .
Ephedrine, with its alpha-adrenergic vasoconstrictor and beta-adrenergic cardiac stimulant effects, would appear to be a suitable agent to combat the adverse haemodynamic effects of propofol. It has been used to counteract similar problems with spinal and epidural anaesthesia 9 . In fit, healthy patients, propofol causes a marked reduction in both systolic and diastolic blood pressure. This can be prevented by the addition of 15 mg or 20 mg of ephedrine to 200 mg of propofol, without causing any clinically significant overshoot in either systolic or diastolic blood pressure or heart rate 10 . In order to assess the safety and efficacy of this technique in the elderly and to determine the optimal ratio of ephedrine to propofol in this group, we studied the haemodynamic effects of adding various doses of ephedrine to propofol in 40 ASA 3/4 patients over the age of 60 years requiring short duration anaesthesia for routine urological surgery.
METHODS
After obtaining local ethics committee approval, and with informed consent, we studied 40 unpremedicated ASA 3 or 4 patients presenting for routine urological surgery. Most patients were undergoing short procedures such as check cystoscopy, so a short-acting agent such as propofol was indicated. Following insertion of an intravenous cannula, monitoring of arterial blood pressure (non-invasive), electrocardiograph (ECG) and peripheral oxygen saturation (S p O 2 ) was instituted and measured at one-minute intervals until the measured parameters were stable. Anaesthesia was induced with one of the study mixtures shown in Table 1 with patients being randomized to a group by the sealed envelope method.
Two anaesthetists, both blinded to the dose of ephedrine administered, were present during the entire study period. One anaesthetist administered the anaesthetic whilst the second anaesthetist recorded the pulse rate, blood pressure and oxygen saturation measured automatically by a Datascope Passport monitor (Datex Instrumentarium, Helsinki, Finland). The propofol/ephedrine mixture was prepared immediately prior to induction by an anaesthetist from a neighbouring theatre according to the randomization. These combinations of propofol and ephedrine remain stable for at least 30 minutes after preparation 10 .
A dose of propofol sufficient to obtund the eyelash reflex was given over 40 seconds and the amount given recorded. Patients were not pre-oxygenated in order to minimize any stress-related cardiovascular responses. Following induction of anaesthesia they breathed a mixture of 60% nitrous oxide in oxygen during the study period and before the start of surgery. Ventilation could be assisted by bag and mask if the anaesthetist judged spontaneous respiration to be inadequate. Following induction of anaesthesia, NIBP was measured at one-minute intervals. Because of variations in patient induction time and in order to minimize differences in timing, we elected to start the study period at the beginning of induction. The study period ended when patients required supplemental anaesthesia or after five minutes, whichever occurred first. No intravenous fluids were to be given unless judged necessary by the anaesthetist administering the anaesthetic. Following the study period, anaesthesia was continued as required for the operation.
Data collected included demographic details, dose of propofol given, dose of ephedrine, heart rate, pulse oximetry and blood pressure recorded at one-minute intervals throughout the study period. Any adverse events were also recorded.
Patient details, induction dose, arterial blood pressure, heart rate and oxygen saturation changes were analysed where appropriate using Students t-test and multivariate analysis of variance (MANOVA)(SPSS for Windows v.6. 1). Covariates incorporated into the analysis were age, weight and pre-induction values of haemodynamic variables. Bonferroni confidence intervals of 0.95 were utilized, and statistical significance was assumed at P<0.05.
RESULTS
Heart rate, S p O 2 , systolic and diastolic blood pressures were compared at one-minute intervals. We had intended the post induction study period to last five minutes, however a large number of the patients required supplementary doses of propofol after three minutes (indicated by an increased respiratory rate and the return of the eyelash reflex). We therefore had complete data for the first three one-minute intervals only, and restricted our analysis to this period. No patients were excluded from the analysis.
There were no statistical differences between groups with respect to age, weight, or dose of propofol administered ( Table 2 ). There were no adverse events such as dysrhythmias, allergic reactions or cardiovascular collapse. No patient required fluid or pharmacological intervention for hypotension.
Changes in heart rate, S p O 2 , systolic and diastolic blood pressures were compared within groups and between groups at one, two and three minutes postinduction.
Within-group analysis
Within-group analysis involved comparing each parameter at one, two and three minutes with the baseline variable, within each treatment group.
Considering heart rate first, in the control group A there was no significant change throughout the study period ( Figure 1) . In all the ephedrine groups there was an increase in heart rate within one minute, sustained throughout the study period. The mean maximal increase was 19 bpm in group B, 12 bpm in group C and 21 bpm in group D. The largest individual change in heart rate was in a patient in group B, increasing from 90 to 160 bpm in one minute.
There was a wide variation in heart rate response in all treatment groups, resulting in wide confidence intervals. Changes within groups failed to reach statistical significance. Effects on systolic and diastolic pressure were slightly different. Following induction systolic and diastolic blood pressure fell significantly in the control group, with mean maximal decreases from baseline of 46 mmHg (P<0.05) in systolic pressure (30% fall) and 18 mmHg (P<0.05) in diastolic pressure (22% fall). In all of the treatment groups diastolic pressure was maintained with no significant difference from baseline in any group. Systolic pressure did not appear to be as well maintained, with a mean maximal fall in group C at 3 minutes of 28 mmHg (16%). However at no time did this fall reach statistical significance (Figures 2 and 3) .
Mean oxygen saturation fell to below 94% in all groups. In 30% of patients, S p O 2 fell to below 90% in at least one time interval. However, the wide confidence intervals meant that changes in oxygen saturation failed to reach statistical significance in any group in this study (Figure 4) .
Between group analysis
In this analysis the relative change in parameters at each time interval in each group was compared with control.
Regarding oxygen saturation, differences between groups failed to reach statistical significance.
Although in individual groups the change in heart rate was not statistically significant, when changes were compared with control, the rise in HR was significantly different from control in groups B (P<0.05) and D (P<0.005) but not in group C (Figure 1 ).
Blood pressure analysis showed that although systolic pressure fell in all groups, this fall was sig- nificantly less in all treatment groups at all times when compared with control. A similar picture was seen when comparing diastolic pressures with control, with significant differences at all times except two minutes comparing groups B and C with control (Figures 2 and 3 ).
DISCUSSION
The average dose of propofol used in this elderly group of patients was lower than in our previous study of younger ASA 1 and 2 patients 10 (2.01 mg.kg -1 , SD 0.43, vs 2.75 mg.kg -1 , SD 0.38). The elderly ASA 3/4 patients in this study had a similar marked hypotensive response to propofol induction and, again, ephedrine was effective at minimizing this hypotensive effect.
In this elderly patient group, ephedrine seems to be more effective at maintaining diastolic than systolic pressure. The 22% maximal fall in diastolic pressure in the control group was reduced to 5% in group B, whilst the 30% fall in systolic pressure in the control group was reduced to a 9% fall in group B. In contrast, in the younger age-group examined in a previous study, systolic pressure was better preserved than diastolic 10 . In the elderly, the lowest dose of ephedrine used (15 mg/200 mg propofol) was effective in maintaining blood pressure. Increasing doses conferred little further stability. The preferential preservation of diastolic blood pressure may be beneficial in terms of maintaining coronary perfusion, but even at the lowest dose of ephedrine, this improvement in blood pressure control was at the cost of clinically relevant increases in heart rate.
Although there was a 30% fall in blood pressure in the control group, there was no associated change in heart rate. In contrast, in the treatment groups there was little change in systolic pressure but a 20% rise in heart rate. Indeed, in several patients the rise in heart rate was marked. Tachycardia can be an important contributor to the induction of perioperative myocardial ischaemia 11, 12 . Elderly patients are especially at risk of this complication.
In all groups, including control, pulse oximetry readings fell to below 95% in most patients for at least one time interval. There was no statistically significant difference within or between groups. Although we did not preoxygenate our patients prior to induction of anaesthesia, respiration was supported if required throughout the study period. This fall in oxygen saturation did not occur in any group in the previous study of younger patients 10 . We consider the changes in S p O 2 after propofol in this study to be clinically significant .
CONCLUSION
The well documented advantages of induction with propofol are offset in the frail and elderly by its marked tendency to cause hypotension and reduce cardiac output. This has led many anaesthetists to use it sparingly, if at all, in this group of patients. We have demonstrated that the addition of 15 mg of ephedrine to 200 mg of propofol effectively minimized the hypotensive response in elderly ASA 3/4 patients. However, the accompanying rise in heart rate may have deleterious effects, especially in patients with ischaemic heart disease. In our sample 75% of patients had some evidence of cardiovascular disease and would be at risk of tachycardia-induced myocardial ischaemia. We would not recommend the use, in elderly patients, of any of the ephedrine/propofol mixtures studied.
